Biohaven (BHVN) stock is lower after its major depression disorder drug did not meet the primary goal of a phase 2 trial …
Biohaven Stock Gaps Lower on Failed Phase 2 Drug Trial
view original post
Biohaven (BHVN) stock is lower after its major depression disorder drug did not meet the primary goal of a phase 2 trial …